BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2538252)

  • 1. Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
    Hirosawa A; Niitani H; Hayashibara K; Tsuboi E
    Cancer Chemother Pharmacol; 1989; 23(4):255-8. PubMed ID: 2538252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
    Shibuya M; Hirosawa A; Niitani H
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
    Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased therapeutic effect on metastatic liver tumors in rats of two-route chemotherapy using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, with temporary clamping of the abdominal aorta.
    Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
    Cancer Chemother Pharmacol; 1990; 26(3):181-7. PubMed ID: 2357764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K; Fukuoka M; Asamoto H; Niitani H; Kimura I; Sakuma A; Yamaguchi Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
    Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
    Nagai N; Hotta K; Yamamura H; Ogata H
    Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cisplatin, ifosfamide and vindesine in the chemotherapy of squamous cell carcinoma of the lung].
    Fujita A; Inoue Y; Sasaki H; Nakajima S; Sekine K; Honda R; Asakawa M; Suzuki A
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2283-7. PubMed ID: 1929449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic chemotherapy in tumor-bearing rats using high-dose cis-diamminedichloroplatinum(II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate.
    Kobayashi H; Hasuda K; Aoki K; Taniguchi S; Baba T
    Int J Cancer; 1990 May; 45(5):940-4. PubMed ID: 2335397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
    Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
    Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing effect of sodium thiosulfate on antitumor efficacy of cisplatin for human carcinoma xenografts in nude mice.
    Inoue M; Shimizu C; Shimizu H; Tanizawa O
    Gynecol Oncol; 1991 Jan; 40(1):34-7. PubMed ID: 1989912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group.
    Shimizu E; Ogura T; Sone S; Nakayama T; Doi H; Takishita Y; Bando H; Kobayashi M; Kimura K; Sasaki H
    Oncology; 1993; 50(1):5-9. PubMed ID: 8380634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II for rat liver tumor.
    Hasuda K; Kobayashi H; Aoki K; Taniguchi S; Baba T
    Int J Cancer; 1989 Aug; 44(2):373-7. PubMed ID: 2759742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tominaga K; Sakurai M; Suga J; Miyaoka H; Sano T; Keicho N
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of ifosfamide and vindesine combination of non-small cell lung cancer in elderly patients and patients with reduced renal function].
    Fujii M; Segawa Y; Matsutomo S; Genba K
    Gan To Kagaku Ryoho; 1990 May; 17(5):1021-5. PubMed ID: 2159266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study.
    Honda R; Fujita A; Inoue Y; Asakawa M; Suzuki A
    Cancer Chemother Pharmacol; 1990; 26(5):373-6. PubMed ID: 2170045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An early phase II trial combining cisplatin, carboplatin and vindesine in patients with inoperable non-small cell lung cancer].
    Haneda H; Koizumi M; Hayashi T
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):227-31. PubMed ID: 10700892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
    Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
    Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma.
    Kawahara M; Furuse K; Kodama N; Yamamoto M; Kubota K; Takada M; Negoro S; Kusunoki Y; Matui K; Takifuji N
    Cancer; 1991 Aug; 68(4):714-9. PubMed ID: 1649683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.